Calithera Biosciences to Participate in the 2018 Citi Global Healthcare Conference
Calithera Biosciences, Inc. (CALA)
Last calithera biosciences, inc. earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
calithera.com
Company Research
Source: GlobeNewswire
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, today announced its participation at the 2018 Citi Global Healthcare Conference. Calithera will host meetings with investors at the conference in New York on Thursday, December 6, 2018. About Calithera Calithera is a clinical-stage biopharmaceutical company focused on fighting cancer by discovering, developing, and commercializing novel small molecule drugs that target tumor and immune cell metabolism. Calithera is headquartered in South San Francisco, California. For more information about Calithera, please visit www.calithera.com. Forward Looking Statements Statements contained in this press release regarding matters that are not historical facts are "forward-looking statemen
Show less
Read more
Impact Snapshot
Event Time:
CALA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CALA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CALA alerts
High impacting Calithera Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CALA
News
- Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat